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Abstract 
Background: Due to anatomical restrictions, the inflammatory response to intracerebral bacterial infections exposes 
swollen brain tissues to pressure and ischemia, resulting in life-threatening damage. Rapid diagnosis and immedi-
ate empirical antibiotic therapy is highly important. However, diagnosing meningitis in patients after neurosurgery 
is complicated, due to brain tissue damage and changes in cerebrospinal fluid (CSF) caused by surgery. Hepatocyte 
growth factor (HGF) is a local, acute-phase protein with healing properties. Previous studies on community-acquired 
septic meningitis reported high levels of intrathecally produced HGF. The present study focused on nosocomial men-
ingitis in assessing the levels of HGF in the CSF.
Methods: HGF concentrations (ELISA) and HGF binding to receptors; c-Met receptor and heparan sulfate proteo-
glycan were determined in CSF samples (surface plasmon resonance). CSF samples from patients with community-
acquired or nosocomial meningitis (217 samples from 135 patients) were compared to those from controls without 
signs of cerebral nervous system involvement (N = 36) and patients with Alzheimer’s disease (N = 20).
Results: Compared to samples from patients that had undergone neurosurgery and had other infectious diseases, 
CSF samples from patients with nosocomial meningitis had significantly higher HGF concentrations (p < 0.001) and 
binding affinity to c-Met (p < 0.001) and HSPG (p = 0.043) receptors. The sensitivity and specificity to identify nosoco-
mial septic meningitis were 69.7 and 93.4 %, respectively. The HGF concentration and binding affinity to HGF recep-
tors were significantly higher in CSF from patients with community-acquired septic meningitis compared to patients 
with aseptic (viral and subacute) meningitis as well as controls (p < 0.001). The sensitivity and specificity to identify 
community-acquired septic meningitis were 95.4 and 95.7 %, respectively.
Discussion: In febrile nosocomial infections that occurred post neurosurgery, HGF assessment could substantially 
improve the differentiation of meningitis from other infections and therefore might be a tool for rapid diagnosis, limit-
ing injuries and guiding antibiotic therapy.
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Background
An invasion of bacteria into the central nervous system 
(CNS) is followed by a rapidly evolving inflammatory 
process that affects the arachnoid space, the pia mater, 
and the cerebrospinal fluid (CSF). This condition leads 
to clinical symptoms of headache, fever, and mening-
ism. The inflammatory response is caused by the release 
of various proinflammatory cytokines from meningeal 
cells into the subarachnoid space. As a result, neutrophils 
move into the subarachnoid space and cause pleocytosis 
in the CSF. The consequences include the breakdown of 
the blood–brain barrier, cerebral edema, reduced cer-
ebral blood flow, focal areas of hypoperfusion, vascular 
thrombosis, ischemia, enhanced glucose metabolism via 
the anaerobic glycolytic pathway, and enhanced lactate 
accumulation in the brain and CSF [1]. Survival from this 
life-threatening condition depends on a rapid diagno-
sis and prompt empirical antibiotic therapy designed to 
cover the likely pathogens.
Other causes of febrile meningitis include acute viral 
meningitis and non-pyogenic meningitis, where the clini-
cal picture is typically sub-acute or chronic. The diagnos-
tic procedures consist of a lumbar puncture to analyze 
the CSF for cells and bacteria, microbiological cultures 
of blood and CSF, serological tests involving PCR and 
antigen-detection, and radiographic techniques [2]. In 
community-acquired meningitis, a combination of dis-
criminating values from the CSF analysis can differentiate 
acute bacterial meningitis from other, non-ambulatory 
causes with quite high sensitivity [3].
Nosocomial meningitis can occur when brain surgi-
cal procedures are complicated by infection [2]. Due 
to underlying CNS disease processes and CNS devices 
in situ, the principal agents of nosocomial bacterial men-
ingitis differ from the agents of community-acquired 
meningitis. For example, in nosocomial infections, slow 
growing, opportunistic microorganisms predominate. 
The CSF leukocyte profile is affected by intracerebral 
hemorrhage, and CSF lactate might be elevated, due to 
ischemia. Moreover, altered consciousness can make it 
difficult to establish a diagnosis in patients on ventila-
tors that develop fever after neurosurgical operations. In 
other words, it is often difficult to determine whether the 
injured brain has been invaded by environmental bacte-
rial flora.
Hepatocyte growth factor (HGF) is produced by mes-
enchymal cells during organ injury. It is produced as a 
single-chain precursor protein, and it is activated at the 
site of injury by proteolytic cleavage, resulting in a dou-
ble-chained active form of HGF [4]. Active HGF stimu-
lates cell division [4] and cell motility [5], and it promotes 
normal morphogenic structure [6] in epithelial cells adja-
cent to injured areas. Thus, HGF induces regeneration 
and repair of damaged tissue [7]. High levels of sys-
temic HGF have been detected during injuries caused 
by infection [8]. In bacterial meningitis, pneumonia and 
acute bacterial gasteroenteritis, there is local production 
of HGF at the site of infection [9–11]. HGF produced 
locally during bacterial infection is biologically active 
[12, 13]. Application of biologically active HGF promoted 
healing of chronic leg ulcers in a pilot study [14]. Effec-
tive antibiotic therapy reduces systemic HGF levels dur-
ing infection [15–17]. HGF might be regarded as a local 
acute phase protein with healing properties [18].
The quality of endogenous HGF binding to receptors 
can be assessed with surface plasmon resonance (SPR), 
an optical technique appropriate for clinical studies that 
can determine the affinity of a protein for several ligands 
[19]. SPR-based assessment of HGF binding affinity for 
its receptors, c-Met and heparan sulfate proteoglycan 
(HSPG), could rapidly and sensitively distinguish HGF 
variants with different biological activities [20–22].
A high level of HGF in the CSF has been reported in 
patients with Alzheimer’s disease, a chronic disorder 
characterized by progressive neuronal degeneration and 
deposits of amyloid plaques and neurofibrillary tangles 
[23]. Cerebral inflammation is also involved in the patho-
genesis of Alzheimer’s disease [24, 25].
We have previously studied the concentration of HGF 
in CSF for patients with community-acquired meningitis 
[9]. We have also shown that the presence of biologically 
active HGF at the site of injury indicates an acute local 
inflammation [18]. The aim of the present study was to 
assess whether HGF concentrations and HGF binding 
affinity for its receptors might serve as markers to dis-
tinguish between meningitis associated with neurosur-
gery and other causes of infection. Therefore, we assessed 
HGF in patients with either community-acquired men-
ingitis or neurosurgery-associated meningitis, and com-
pared the results to either patients with Alzheimer’s 
disease or controls with normal CSF.
Methods
CSF samples
This study was performed in Linköping, Sweden. The 
CSF samples from patients with septic (pyogenic) and 
aseptic meningitis were collected at the University Hos-
pital in Linköping, Sweden, over the 8-year period of 
2006–2013. The CSF specimens from patients with com-
munity-acquired infection or controls were collected 
after lumbar punctures and handled promptly. In one 
patient the sample was collected from ventricular drain. 
The samples from patients that had undergone neurosur-
gical intervention were collected from ventricular drains. 
The samples were collected and centrifuged (3000×g 
for 15 min) and then stored in in polypropylene tubes at 
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−70  °C until use. CSF samples from patients diagnosed 
with Alzheimer’s disease were obtained from the Mem-
ory Clinic, Skåne University Hospital in Malmö, Sweden. 
The Regional Ethics Committees in Linköping and Lund, 
respectively, approved the study protocols. Five patients 
with pleocytosis of unknown origin and one patient with 
Creutzfeldt-Jakob disease (positive western blotting for 
protein 14-3-3 in CSF) were excluded. The remaining 
samples (n  =  274) were assigned to one of six groups, 
depending on the type of meningitis (Group 1–4) or 
controls (Group 5, 6) (Fig. 1). Please note the difference 
between the number of samples (n) and the number of 
patients (N) in each group (Additional file 1).
CSF sample groups
Community‑acquired meningitis
Group 1: septic meningitis (n  =  22 samples) Patients 
with community-acquired acute bacterial meningitis 
(N  =  20) had a median age of 62  years (range 24–75; 
with 7 females). In 2 cases, samples were collected on 
two occasions (CSF samples, n  =  22). The cases pre-
sented with fever, CSF polynuclear pleocytosis, and 
elevated CSF lactate and protein levels. The causes were 
identified as Streptococcus pneumonia (N  =  6), Hae-
mophilus influenzae (N  =  2), Listeria monocytogenes 
(N = 1), Streptococcus intermedius (N = 3), α-hemolytic 
streptococci (N  =  1), rickettsial meningitis (N  =  1), 
Coagulase-negative staphylococcus (N = 1), Cryptococcus 
neoformans (N = 1), Aspergillus (N = 1), Staphylococcus 
aureus (N =  1), and unknown (N =  2), due to negative 
results in microbiological assessments.
Group 2: Aseptic meningitis (n = 46 samples) Patients 
with viral or subacute meningitis or encephalitis were 
considered one group in statistical calculations. The labo-
ratory findings included CSF pleocytosis, normal CSF 
lactate levels, and negative blood and CSF cultures.
 – 15 patients had viral meningitis (median age 41 years, 
range 21–88, 7 females). Laboratory assessments 
revealed Herpes zoster (positive PCR; N =  4), enter-
ovirus (positive PCR; N =  5), and negative results in 
the laboratory assessments (N = 6). In 1 case, samples 
were collected on two occasions (n = 16 samples).
  – 30 samples were collected from patients with subacute 
meningitis or encephalitis (N = 30). Laboratory assess-
ments revealed Borrelia burgdorferi (positive intrathe-
cal anti-borrelia antibodies; N = 28), syphilis (positive 
antibodies in serum; N  =  1), and highly suspected 
tuberculosis (The patient had been treated for tubercu-
losis, had clinical CNS symptoms, and pleocytosis but 
direct microscopy of CSF, PCR, and cultures were neg-
ative; was treated successfully with anti-tuberculosis 
medicine, N = 1).
Nosocomial meningitis
CSF samples (n  =  149) were collected from patients 
(N = 69) that were admitted to the Department of Neu-
rosurgery, University Hospital in Linköping, Sweden. The 
patients had undergone a neurosurgical procedure, and 
the management was complicated with infection. Thus, 
several CSF specimens were collected from some patients 
on different occasions. Ventilator associated pneumonia 
and meningitis were the differential diagnoses of infec-
tion in the majority of cases. Antibiotic therapy was ini-
tiated or changed to broad spectrum antibiotics by the 
physician in charge, directly after cultures of blood, CSF, 
catheters, and drains were taken.
Because no golden standard is available to define the 
diagnosis in post neurosurgery patients that develop 
fever, among the CSF samples, two major groups were 
identified based on medical history, the clinical judgment 
of physician in charge, the follow-up and the diagnose 
code in medical records.
Group 3: Nosocomial meningitis (n = 33 samples) CSF 
specimens (n = 61) were collected from patients (N = 29, 
median age, 62 years, range 21–76; 14 females) that had 
undergone brain tumor surgery (N  =  8), intracerebral 
hemorrhage (N =  15), shunt dysfunction (N =  3), skull 
fracture (N  =  2), or two different periods of disease 
(N  =  1). In these patients, microbiological assessments 
Fig. 1 Flow chart of the selection of CSF specimens from patient and 
control groups. Extra samples are the samples taken during stay on 
ward from patients with nosocomial meningitis
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yielded bacterial growth or CSF pleocytosis, and they 
were treated for bacterial meningitis. Prior to antibiotic 
therapy, 33 CSF samples were collected (in three cases, 
samples were collected on 2 occasions). The CSF cultures 
showed growth of Coagulase-negative staphylococcus 
(N = 7), Propionibacterium acnes (N = 5), Enterococcus 
faecalis (N  =  2), α-hemolytic streptococci (N  =  1), and 
Candida glabrata (N =  1). In blood cultures, we found 
Pseudomonas aeroginosa (N = 1) and Lactococcus lactis 
(N = 1). 12 patients had negative cultures.
In 13 patients, CSF samples were collected before and 
after therapy at 2–5 occasions (totally 42/61 specimens). 
Assessments of the 13 patient reports indicated two 
sub-groups:
a. CSF samples were collected both before and after 
successful therapy (N = 7);
b. CSF samples were collected from patients that failed 
therapy or from patients before therapy was initiated 
(N = 6).
Group 4: Other nosocomial infections (n = 76 samples) 
CSF specimens (n  =  76) were collected from patients 
(N = 37) (median age 55 years, range 0.5–81) that under-
went neurosurgery for tumors (N  =  6), cerebral hem-
orrhage (N =  23), shunt dysfunction (N =  5), fractures 
(N =  2), or surgical complications (N =  1). The course 
of treatment was complicated with bronchitis or pneu-
monia (N = 19, n = 50), other infections (N = 5, n = 7, 
urinary tract infection, skin and soft tissue infection) or 
unverified or treated infections (CSF samples obtained 
after 1 week treatment) (N = 13, n = 19).
Among the nosocomial infections, 12/149 CSF speci-
mens were unclear cases (died on ward or were trans-
ferred to another hospital before a diagnosis was set) and 
were excluded from statistical calculations.
Controls
Group 5: Alzheimer’s disease (n = 20) CSF samples were 
collected from patients (N  =  20) with a median age of 
78.5  years (range 61–86, 15 females) that were diag-
nosed with Alzheimer’s disease at the Memory Clinic, 
Skåne University Hospital in Malmö. The patients had all 
undergone a routine lumbar puncture, cognitive testing, 
and computed tomography or magnetic resonance imag-
ing of the brain as part of the dementia investigation. The 
revised DSM-III and NINDS-ADRDA criteria were used 
for diagnosis of Alzheimer’s dementia [26, 27].
Group 6: Normal CSF (n = 37) This group consists of 
two subgroups, but it is considered one group in sta-
tistical calculations. One subgroup included patients 
(N  =  19) with a median age of 50  years (range 24–74; 
7 females, in one case, samples were collected on two 
occasions) (n  =  20). These patients underwent lumbar 
puncture to rule out meningitis, and they had normal 
CSF. The other subgroup comprised patients (N  =  17) 
with a median age of 58  years (range 48–78  years, 10 
females). These patients had very subtle cognitive symp-
toms, and they were judged to be cognitively healthy 
after a dementia evaluation at the Memory Clinic, Skåne 
University Hospital in Malmö.
Analysis of ligand‑binding affinity with surface plasmon 
resonance
The biological activity of HGF was analyzed with SPR. 
We measured the binding affinity to HSPG (Sigma-
Aldrich, St. Louis, MO, USA) and to a c-Met recombi-
nant chimera (R&D Systems), as previously described 
[19]. Briefly, SPR measurements and ligand immobili-
zation procedures were conducted with a 760-nm light 
beam emitted in a fully automatic, Biacore 2000 system 
(GE-Healthcare GmbH, Uppsala, Sweden), equipped 
with four flow cells. In all experiments, the flow cell tem-
perature was 25 °C. The running buffer contained 0.01 M 
HEPES, pH 7.4, 0.15 M NaCl, 3 mM EDTA, and 0.005 % 
surfactant P20 (HBS-EP; GE-Healthcare GmbH). 
Ligands were coupled to carboxymethylated dextran 
CM5 chips (GE Healthcare GmbH) with conventional 
carbodiimide chemistry: 200  mM  N-ethyl-N0-(3 dieth-
ylaminopropyl) carbodiimide and 50  mM  N-hydrox-
ysuccinimide. The activation time was 7  min, followed 
by a 7-min ligand injection. Deactivation of the remain-
ing active esters was performed with a 7-min injection 
of ethanolamine/hydrochloride, pH 8.5. A flow rate of 
5 μL/min was used in the immobilization and measure-
ment procedures. The HSPG (Sigma-Aldrich, St. Louis, 
MO, USA) solution contained ≥400  μg/mL protein 
and 400  μg/mL glycosaminoglycan; this solution and 
the recombinant c-Met receptor chimera (100  µg/mL, 
R&D Systems, Minneapolis, MN, USA) were diluted 1:5 
in 10 mM acetate buffer, pH 4.5. This buffer maintained 
the reaction below the isoelectric points of the proteins 
to enhance electrostatic interactions between the dex-
tran matrix and the ligands. The contact time was 7 min, 
which resulted in immobilization levels between 200 and 
1000 response units (RU).
CSF samples were thawed, centrifuged at 3000×g for 
10 min, and diluted 1:1 in phosphate buffered saline solu-
tion (PBS, pH 7.4; Apoteket AB, Umeå, Sweden). CSF 
regeneration was induced by adding an equal volume 
of 1 M NaCl and 10 mM glycine, pH 2, followed by one 
injection of borate, pH 8.5. The positive control consisted 
of HGF produced by leukocytes from a healthy volunteer; 
the negative control was PBS. Both were included at the 
beginning and end of each run to confirm the reliability 
of the surfaces.
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Measurements of HGF concentrations in CSF
A specific enzyme-linked immunosorbent assay (ELISA) 
kit (Quantikine Human HGF immunoassay, minimum 
detectable limit: 0.04 ng/mL; R&D Systems, Minneapolis, 
MN, USA) was used to determine HGF concentrations 
in CSF, according to the manufacturer`s instructions. All 
measurements were performed with an ELISA reader 
(Expert96; AsysHitech GmbH, Eugendorf, Austria) at 
450  nm, which was calibrated with the recombinant 
human HGF reference samples and the standards pro-
vided in the kit.
Routine laboratory assessments
CSF was analyzed to determine parameter values at the 
Departments of Clinical Chemistry, University Hospi-
tals, in Linköping and Malmö, Sweden. All cultures, PCR 
assays, antigen detection assays, and serological assess-
ments were performed at the Department of Microbiol-
ogy, University Hospital, Linköping, Sweden.
CSF-cells Performed by manual phase contrast micros-
copy (Zeiss) using Jessen Chamber for counting the num-
ber of erythrocytes and leukocytes (polymorphonuclear 
neutrophils and monocytes).
CSF lactate Performed using benchtop blood gas ana-
lyzer ABL 800 (Radiometer Medical ApS Denmark).
Antigen detection Antigen (Streptococcus pneumonia, 
Haemophilus influenza, Nisseria meningitides group A, 
group B/Escherichia coli K1, group C and group Y/135, 
Streptococcus agalactiae) was detected by latex aggluti-
nation method Pastorex Meningitis™ (Bio-Rad, France).
CSF culture Performed in aerobe and anaerobe flasks as 
well as in Hematin plates.
Lyme neuroborreliosis Intrathecal antibodies against 
Borrelia burgdorferi were detected by capture Elisa 
technique.
Virus detection PCR Herpes virus type 1 and 2 (HSV1, 
HSV 2) and HZV DNA were detected by PCR. Human 
enterovirus (HEV) was analyzed by automated instru-
ment (Cepheid GeneXpert).
Statistical analysis
Because the HGF concentrations and binding affinity data 
were not normally distributed, we compared values before 
and after therapy with the Kruskal–Wallis test followed by 
the Mann–Whitney U test or the Wilcoxon matched pairs 
test. All analyses were performed with Graph Pad Prism 
version 5 (San Diego, CA, USA). Values are expressed as the 
median. P-values <0.05 were considered statistically signifi-
cant. The sensitivity, specificity, positive predictive values, 
and negative predictive values were calculated manually. 
The intra- and inter-assay coefficient of variation (CV) for 
determination of HGF concentration was calculated manu-
ally and was found to be 12.9 and 11 %, respectively.
Results
CSF specimens
The community-acquired septic meningitis showed sig-
nificantly higher HGF concentration (p = 0.0133), as well 
as HGF binding affinity to the c-Met and HSPG recep-
tors (p = 0.0007 and p = 0.0009, respectively) compared 
to nosocomial meningitis. CSF samples from patients 
with septic meningitis (including both community-
acquired and nosocomial) was significantly higher in 
HGF concentrations (p = 0.0014), HGF binding to HSPG 
(p  <  0.0001), and HGF binding to c-Met (p  <  0.0001) 
compared to samples from patients with aseptic (viral 
and subacute) meningitis. CSF samples from patients 
with septic meningitis was higher from samples from 
the control group (patients with normal CSF) and from 
patients with Alzheimer’s disease in HGF concentration 
(p  <  0.0001, p  =  0.0010, respectively), HGF binding to 
HSPG (p  <  0.0001 and p =  0.9, respectively), and HGF 
binding to c-Met (both p < 0.0001).
Compared to samples from patients that had under-
gone neurosurgery and had other infectious diseases, 
CSF samples from patients with nosocomial meningitis 
had significantly higher HGF concentrations (p < 0.0001) 
and HGF binding affinity to c-Met (p  <  0.0001) and 
HSPG (p = 0.043) receptors.
CSF samples from patients with Alzheimer’s dis-
ease had significantly higher binding affinity to HSPG 
and c-Met compared to samples from patients with 
aseptic meningitis (p  <  0.0001), samples from controls 
(p < 0.0001), and samples from patients that had under-
gone neurosurgery and had infections other than menin-
gitis (p < 0.0001) (Table 1; Fig. 2).
Estimations
We measured the binding of CSF-derived HGF to c-Met 
receptors in the SPR system. We used a cut off value of 
10 response units (RU) to diagnose pyogenic meningitis 
in nosocomial (sensitivity 69.7 %, specificity 93.4 %, posi-
tive predictive value 82.1 % and negative predictive value 
87.6  %) (Table  2a) and community-acquired infections 
(sensitivity 95.4 %, specificity 95.7 %, positive predictive 
value 91.3 %, negative predictive value 97.8 % (Table 2b).
Correlation analysis in nosocomial cases
Statistical dependence between the HGF variables (c-Met, 
HSPG, and ELISA) and white blood cells was tested in 
cases having nosocomial meningitis (G3) and other noso-
comial infections (G4) by using Spearman’s rho. In these 
cases, the white blood cells count correlated to HGF 
amounts ELISA (0.44; p  <  0.001), c-Met binding (0.56; 
p < 0.001), and to HSPG binding (0.28; p = 0.004). These 
results suggest that some diagnostic information is shared 
between white blood cell count and HGF variables, and, 
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to elucidate the independent value of HGF, we further 
subdivided the 109 nosocomial cases into two groups 
according to WBC (<10 … and >10….). All 30 cases with a 
low WBC count had a low c-Met binding (<10 RU) and in 
this group 2 had septic meningitis (2/30 = 7 %). Fifty-one 
nosocomial cases had a high WBC count but a low c-Met 
binding and 8 of these had meningitis (8/51  =  16  %). 
Among the 28 cases with both a high WBC count and a 
high c-Met binding, 23 were diagnosed with septic men-
ingitis (23/28 =  82  %). The difference in the proportion 
of cases with meningitis between the two last groups was 
statistically significant (p  <  0.001) indicating that there 
is independent diagnostic information in c-Met binding 
(additional to that of WBC count).
Correlation between the HGF variables (c-Met, HSPG, 
and Elisa) and red blood cells (>500 × 109, n = 132) was 
tested by using Spearman’s rho. In these cases, the correla-
tions to HGF concentration Elisa, c-Met binding and HSPG 
binding were R = 0.12, 0.20 and 0.40 respectively (Table 3).
Monitoring
In some patients with nosocomial meningitis (N =  13), 
CSF samples had been collected before and after antibi-
otic therapy. We found that CSF-derived HGF binding to 
c-Met receptors decreased after treatment in CSF sam-
ples from patients that responded to antibiotic treatment. 
However, the change did not achieve significance (N = 7, 
p = 0.06). In contrast, HGF binding to c-Met increased 
Table 1 The CSF samples in groups (G1–G6)
All values represent median (range)
a Negative values in surface plasmon resonance are reported as 0
b nd not
Groups 1–6 Red blood cells (×109) White blood cells (×109) C‑Met binding (RU)a HSPG binding (RU)a HGF (ng/ml)
Septic community-acquired 
meningitis (n = 22)
200 (0.1–49,000) 400 (3.6–8400) 56 (9.6–965.3) 6.7 (0–129) 3.08 (0.58–17.51)
Aseptic/Subacute meningitis 
(n = 47)
2.2 (0–1820) 58 (0.6–1042) 0 (0–462) 0 (0-134) 0.59 (0.18–2.1)
Septic nosocomial meningitis 
(n = 33)
7000 (1–75,000) 164 (0-2000) 27.3 (0–116.4) 0 (0–81.2) 2.04 (0.125–11.59)
Nosocomial other infections 
(n = 76)
3500 (0–350,000) 18 (0.2-545) 0 (0–25) 0 (0–3.8) 0.57 (0–3.26)
Alzheimer’s disease (n = 20) ndb ndb 7.4 (0–26.1) 1.3 (0–16.2) 0.71 (0.43–1.47)
































































































































































































































Fig. 2 Properties of HGF derived from different CSF samples were analyzed by using surface plasmon and ELISA techniques. a Binding to c-Met 
receptors; b Binding to HSPG receptors; c HGF concentrations (median). * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
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in CSF samples from patients that did not respond to 
therapy; again, the change was not statistically significant 
(N  =  6, p  =  0.07). However, the post-treatment levels 
of binding differed significantly between responder and 
non-responder sub-groups (p = 0.0153, Mann–Whitney 
test; Fig. 3).
Discussion
In the present study, we show that an assessment of CSF-
derived HGF binding to c-Met receptors can be used to 
substantially improve the differentiation between infec-
tion in the injured brain after surgery and other nosoco-
mial infections, such as ventilator-associated pneumonia. 
In addition, this assessment can be used to differentiate 
between community-acquired septic meningitis and 
aseptic meningitis with high sensitivity and specificity.
Due to the challenges in establishing a diagnosis, and 
the lack of gold standards, physicians are motivated to 
treat suspected infections in serious diseases with broad-
spectrum antibiotics. The emerging problems of mul-
tiple-resistance bacteria, high costs, and complications 
related to new antibiotics have called for diagnostic tests 
that can minimize antibiotic consumption.
Currently, the diagnosis of bacterial meningitis remains 
based on standard methods of direct microscopy, differ-
ential analyses of white blood cells, lactate, and protein, 
and cultures of blood and CSF [3]. However, post-neu-
rosurgical infections are difficult to distinguish from the 
effects of neurosurgical procedures [28, 29]. For example, 
when patients develop fever within days after surgery, a 
determination of cells and lactate in the CSF cannot pro-
vide reliable information. Moreover, due to prophylaxis 
treatments, the cultures are negative in a large group of 
patients, and the presence of skin flora, like Coagulase 
negative Staphylocococcus or Propionbacterium acnes, 
may indicate either infection or contamination.
In the present study, we measured HGF concentration 
and receptor-binding affinity in CSF samples. Consist-
ent with previous observations regarding presence and 
quality of HGF in body fluids during infection [30, 31], 
we found a significant difference in CSF-derived HGF 
concentrations between samples from patients with 
community-acquired septic meningitis and samples from 
those with aseptic meningitis. Furthermore, we observed 
that binding of CSF-derived HGF to the c-Met receptor 
could differentiate meningitis from other causes of fever 
in patients that had undergone neurosurgery; this assay 
had quite high specificity (=93 %), and it could rule out 
nosocomial meningitis in 88  % of cases (negative pre-
dictive value, 88  %; Table  2a). There was no statistically 
significant difference in the CSF-derived HGF concentra-
tions before and after therapy but the levels were lower 
in cases that responded to antibiotics compared to levels 
in nonresponders (Fig.  3); therefore, in part, the patho-
logical difference between damage caused by surgery and 
that caused by infection might be the presence or absence 
of external pathogens.
Previous studies have reported elevated concentra-
tions of CSF-derived HGF in Alzheimer’s disease [32]. 
Recently, we reported high HGF concentrations, but low 
biological HGF activity during chronic inflammation 
[33]. In the present study, we observed that HGF bind-
ing affinity for HSPG, an indicator of HGF biological 
activity [21], was significantly lower in viral and suba-
cute meningitis than in septic meningitis. Because it has 
been shown that inflammation is present in Alzheimer’s 
disease [25], we expected high HGF concentrations 
Table 2 The sensitivity and  specificity for  the diagnos-
tic accuracy of  CSF-derived HGF binding affinity to  c-Met 
receptor; a cut off  value =  10.0 response units (RU) was 
used to diagnose septic meningitis in community-acquired 
and nosocomial meningitis
Values represent the numbers of patients in each group. The sensitivity 
and specificity of the diagnostic test were 69.7 and 93.4 %, respectively (a: 
nosocomial meningitis/other febrile infections post neurosurgery) and 95.4 % 
respective 95.7 % (b: community acquired septic/aseptic meningitis)
Sub‑groups Nosocomial fever
C‑met affinity Meningitis Other infections Total
≥10 23 5 28
<10 10 71 81
Total 33 76 109
Sub‑groups Community acquired
C‑met affinity Septic meningitis Aseptic meningitis Total
≥10 21 2 23
<10 1 45 46



















Efficient therapy Therapy failure
Fig. 3 HGF binding to c-Met receptor in CSF was measured before 
(circle) and after (square) treatment in 13 cases with nosocomial 
meningitis. These were divided into groups based on whether they 
responded effectively to therapy (Efficient therapy, N = 7) or did not 
respond to therapy (Therapy failure, N = 6); * p < 0.05
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(ELISA), but low binding affinity to HGF receptors 
(HSPG, C-Met, SPR). Surprisingly, we observed that the 
HGF profile was similar to that in acute inflammation; 
in the CSF from patients with Alzheimer’s disease, the 
HGF binding affinity to HSPG was significantly higher 
than in the samples from all other groups, except for the 
samples from patients with community-acquired sep-
tic meningitis (Table  1). Proteoglycans possess diverse 
physiological roles, particularly in neural development, 
and are also implicated in the pathogenesis of neuro-
degenerative diseases [34–36]. Our observation of high 
binding affinity of CSF to HSPG in SPR might indicate 
the role of HSPG in etiology and pathophysiology of Alz-
heimer’s disease, not relating to presence or biological 
activity of HGF in CSF.
Limitations: The present work has limitations that 
should be addressed in future prospective and independ-
ent multicenter studies. The source of collection of CSF 
differed in community-acquired meningitis (lumbar 
puncture) from nosocomial infections after surgery (ven-
tricular drains). As far as we know there are no reports 
about differences in concentration of circulating proteins 
in CSF collected by lumbar puncture or from ventricular 
drains. The major message of this study is the higher level 
of HGF in CSF in patients who suffered from nosocomial 
septic meningitis compared to other nosocomial infec-
tions and the method of collection of CSF did not differ 
between these patient groups.
The patients that had undergone neurosurgery had 
high red blood cell count in CSF that might indicate a 
passive transfer of HGF from blood into CSF [37]. There 
were no matched blood samples to calculate the blood–
brain barrier damage and to assess the intrathecal pro-
duction of HGF. However, in the previous study [9] we 
have reported intrathecal production of HGF during 
septic meningitis. The results show a significantly higher 
CSF HGF levels in nosocomial septic meningitis com-
pared to other nosocomial infections in the post- neuro-
surgery patients that had low correlation to the number 
of cells in CSF.
The samples were collected during several years and 
kept frozen until they were analyzed. We have previ-
ously studied the stability of HGF in blood and feces and 
observed that HGF was stable in these body fluids dur-
ing longer storage and several freeze–thaw cycles [38, 
39].
Conclusions
Consistent with our previous studies, from the present 
study, we concluded that a determination of HGF in 
CSF might be used as an indicator, complementary to 
clinical status and routine laboratory findings, for diag-
nosing bacterial invasion into the CSF at an early stage 
of disease. The benefit of this kind of diagnosis is that it 
can limit the brain damage and guide the selection of an 
appropriate antibiotic therapy, particularly in nosocomial 
infections, where standard diagnostic methods are of 
limited value.
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